Operation Warp Speed, the U.S. government’s crash program to inoculate 300 million Americans against the coronavirus, includes a number of pharmaceutical partners like Emergent BioSolutions in Baltimore. CBS News correspondent David Martin toured one of Emergent’s manufacturing suites where the company is producing two COVID-19 vaccines awaiting FDA approval.
{iframe}https://www-cbsnews-com.cdn.ampproject.org/c/s/www.cbsnews.com/amp/news/covid-19-vaccine-bulk-manufacturing-operation-warp-speed-60-minutes-2020-11-12/{/iframe}